The global intravenous infusion pump market size is expected to reach USD 9.9 billion by 2030 and is expected to expand at 8.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are responsible for the crucial growth of the infusion pump industry. Smart infusion pumps are considered an advancement that will give a boost to the market as it embeds error-reduction software and customized drug libraries. According to a study conducted by Mindray Medical company in 2018, infusion pumps are the most conventional hospital rental equipment.
The rise in diseases like cardiovascular and cancer continues to drive the demand for intravenous infusion pump devices. Intravenous infusion pumps ensure regulated, controlled, and error-free delivery of medications and nutrients. Such processes are essential while treating patients via chemotherapy or radiation therapy. These are very complex processes and require a very precise dosage of medication. The amalgamation of factors like shift in technology, automation, and standardized dosing for intravenous pump devices are anticipated to make therapy more convenient and user-friendly for patients.
The intravenous infusion pumps industry witnessed growth in demand in 2020 due to the COVID-19 pandemic. This was because infusion pumps are the most common medical devices used in health emergencies. As the pandemic burdened healthcare facilities due to increased use, the demand for medical devices like infusion pumps witnessed a major surge. In May 2020, the FDA also issued an umbrella authorization for the emergency use of infusion pumps and infusion pump accessories. This increased use by healthcare providers catered to the increased demand for infusion pumps.
Request a free sample copy or view report summary: Intravenous Infusion Pump Market Report
Volumetric infusion pumps emerged as the largest product segment in 2022, owing to the increasing use of delivery fluids such as nutrients and medications during emergencies and treatments like chemotherapy
The insulin infusion pumps segment is projected to register the highest CAGR over the forecast period as the burden of diabetes increases globally
The pediatrics/ neonatology segment dominated the market in 2022 in terms of disease indication as there have been growing incidences of premature births, which require optimum care and nutrition
The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of geriatric and diabetic patients in the region
Grand View Research has segmented the global intravenous infusion pump market based on product, disease indication, and region:
Intravenous Infusion Pump Product Outlook (Revenue, USD Million, 2018 - 2030)
Volumetric Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Enteral Infusion Pumps
Ambulatory Infusion Pumps
Patient Controlled Analgesia (PCA)
Implantable Infusion Pumps
Others
Intravenous Infusion Pump Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
Chemotherapy
Diabetes
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
Others
Intravenous Infusion Pump Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Netherlands
Belgium
Switzerland
Russia
Sweden
Asia Pacific
India
Japan
China
Australia
South Korea
Malaysia
Indonesia
Singapore
Philippines
Thailand
New Zealand
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Middle East & Africa
South Africa
Saudi Arabia
UAE
Israel
Egypt
List of Key Players in Intravenous Infusion Pump Market
Baxter International
B. Braun Melsungen AG
Medtronic
Micrel Medical Devices SA
Boston Scientific Corporation
CareFusion Corporation
Fresenius Kabi
Smiths Medical
F. Hoffmann-La Roche Ltd.
Tandem Diabetes Care, Inc.
Terumo Corporation
Mindray
Moog Inc.
IRadimed Corporation
"The quality of research they have done for us has been excellent..."